Introduction
Proton nuclear magnetic resonance imaging (MRI) is a comparatively new diagnostic test now being used in the evaluation of human disease [1 -3] . This non-invasive technique provides hydrogen "maps" of cross-sectional anatom y with superior spa tial and contrast resolution, yet without the ionizing radiation associated with conventional radiographic procedures. The signal intensity derived from vari ous biological tissues reflects differences in water content, m olecular environm ent, and m otion of pro tons. For example, soft tissues like muscle and bone marrow that have a relatively high water content and fluid molecular configuration, generate a high signal, whereas bones and gallstones with rigid m olecular lattices [4] and rapidly flowing blood in vessels [5] have a characteristically low N M R signal. For static tissues, the primary determ inants of signal strength, and thus contrast between tissues, are spin-lattice (T J and spin-spin (T2) relaxation times and proton density. The well-recognized proton relaxation enhancement observed with even small am ounts of paramagnetic substances led to the introduction of paramagnetic pharmaceutical agents in living sys tems to deliberately alter tissue relaxation behaviors and tissue contrast on MR images [6] [7] [8] [9] . These manipulations of tissue relaxation phenom enon, first tested in animals, are now being extended to patients in clinical trials [10, 11] . Although the lanthanide cations, in particular, gadolinium and the transition metal cations, such a chromium, manganese, and iron provide marked proton relaxation enhancem ent in aqueous solutions, the use of these cations in clini cal practice is limited by their prolonged retention in living subjects and their recognized side effects, vari ably including bone marrow depression, myocardial damage, and renal failure [12] . To prom ote rapid clearance and to reduce toxicity, highly stable che lates of these cations using ED T A , D TPA , and other complexons have been proposed and tested with con siderable success [13 -16] , Yet another approach to the safe alteration of tis sue relaxation behavior is the application as contrast agents of stable, non-toxic radicals, such as, the ni troxyl radicals of type 1, 2, and 3 [17 -19] , Although effective as relaxation enhancers, nitroxyles in aque ous solutions possess approximately a ten-to twentyfive fold weaker effect than gadolinium complexes in I-0
the same molar concentration. Nevertheless, the nitroxyl radicals have other favorable characteristics for use as contrast agents including ready conjuga tion to carrier molecules without concern for dissoci ation and the dem onstrated ability to penetrate cells, unlike metal complexes. In recent years, numerous M RI studies testing nitroxyl compounds of type 1-3 as M RI contrast enhancing drugs have established their effectiveness for enhancem ent of renal [17] , cardiac [19] , soft tissue [18] , and cerebral lesions. These agents have been observed to pass selectively through the blood-brain barrier (BBB) at sites of disease where the barrier had been disrupted [18] . M onosaccharides, such as D-glucose, D-mannose, and 2-acetamido-2-deoxy-D-glucose are known to participate in inter-and intra-cellular recognition and transport processes, such as crossing the BBB and carbohydrate-specific endocytosis [20] [21] [22] [23] , Thus we hypothesize that a replacem ent of the substituent X in 1 and 2 by a monosaccharide moiety should lead to a unique distribution of the spin label including passage through the BBB and cellular uptake by cerebral tissue. Such a biodistribution pattern could yield patterns of contrast enhancem ent on M RI re flecting regional differences in carbohydrate metabolism in the brain. Further, since carbohy drates are well retained by liposomes, such nitroxyl derivatives might also be used effectively in liposome form ulations [24] , Although a substantial am ount of information is available on the techniques of spin labeling of blocked disaccharides and, in particular, on polysaccharides, such as, chitin, chitosan, dextrans, xylan, guar gum, agarose, cotton fibers, sialic acid residues of glycopro teins and many m ore, there is essentially no inform a tion available on the synthesis of selectively spin labeled unblocked, water soluble monosaccharides [25] [26] [27] , Since one of the requirem ents for a suitable intraveneous contrast agent is solubility in water, the w ater insoluble, fully blocked nitroxyl derivatives of carbohydrates, described in literature to date, are of little value for M RI. Furtherm ore, for diffusion of a contrast agent through a phospholipid m em brane, such as, BBB, it is im portant that the contrast agent is not only water soluble but also possesses a certain degree of lipophilicity. This property can be provided to a spin labeled carbohydrate by the relatively lipophilic nitroxyl group and by a judicious choice of bridge elem ents, between the carbohydrate and the nitroxyl moieties. Thus, as a result of these require ments the preparation of seemingly simple unblocked nitroxyl derivatives of glucose becomes a cum ber some and formidable task involving special regio-and stereoselective methodologies bearing in mind that the nitroxyl m oieties are sensitive to acidic conditions [26, 28] , and are, comparatively, stable in neutral and alkaline environm ent. Now, for the first time, we would like to report on methodologies which are applicable to the synthesis of glucose derivatives which are selectively spin labeled at the positions, 1, 2, 3 and 6 of the glucose framework.
Results and Discussion
A num ber of new well-defined spin labeled glucose derivatives were synthesized in quantity using selective blocking and deblocking procedures. A uthenticated starting m aterials, 2,3,4,6-tetra-0-acetyl-a-brom oglucose (4), 2,3,4,6-tetra-O-acetyl-Dglucose (8), D-glucurono-l,2-isopropylidene-3,6-lactone (20) and methyl 2,3,4-tri-O-trimethylsilyl-a-Dglucopyranoside (24) were prepared in accordance with the literature procedures (see Experimental).
Com pounds 7 ,1 1 , and 14 which are spin labeled at the position 1 of the glucose molecule were syn thesized by selectively preparing the 0-acetyl deriva tives 4 and 8 which were then converted to the cor responding nitroxyl derivatives 6 ,1 0 and 13 which, in turn, were selectively deblocked to give products 7, 11 and 14, respectively (Scheme I).
The 2-amino-2-deoxy-D-( + )-glucose (15) was spin labeled either by a direct route using the acid chloride 16 in the presence of sodium bicarbonate, or, via a transfer reagent 18 (Scheme II).
Spin labeling at the position 6 of the glucuronic acid was achieved by a selective ring-opening reac tion of D-( + )-glucurono-l,2-isopropylidene-3,6-lactone (20) with 4-amino-2,2,6,6-tetramethylpiperidine-l-oxyl (21) (Scheme III). Subsequent re moval of the protection group of compound 22 under mildly acidic conditions gave the product 23 (Scheme III). The choice of the acidic environment in this deblocking reaction is critical since the ni troxyl radicals are susceptible to acidic conditions below pH 4 [28] . 
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blocked interm ediate in situ with a 30% aqueous hydrogen peroxide solution in the presence of sodium tungstate as a catalyst resulted in the de blocked nitroxyl derivate 36 (Scheme VI).
During this work, the progress of all reactions and the purity control of products was routinely m oni tored by TLC analyses. The yields of the pure iso lated products varied between 40 and 60 percent.
All new compounds were characterized by m icro analyses, and, were appropriate, by a com bination of IR and EPR spectroscopies and mass spectrom etry. Compounds 7, 11, 14, 17, 23, 26, 29, 32, 33 and 36 were water soluble and amenable to m easurem ents of their effects on the Tj and T 2 relaxation times of water and human plasma. The relaxation times T] and T2 of water and human plasma in the presence of these compounds were substantially shorter than those in the absence of these com pounds (Table I ). The T, and T2 values for plasma were found to be shorter than those obtained for w ater (Table I) . This result is, in part, contrary to results obtained in our laboratory with various nitroxyl derivatives other than carbohydrates [30, 31] A lthough the new relaxation enhancers are all w ater soluble, it is, nevertheless, expected that be cause of two different nitroxyls used and because of various bridge elements between the nitroxyl and carbohydrate moieties, the new compounds will pos sess a range of partitioning properties which will make some of them more suitable for diffusion through m em branes such as BBB. This topic is now actively pursued in our laboratories.
Finally, it is expected that the new compounds will be of value not only in M RI studies but also in a host of o ther applications in various biological disciplines.
Experim ental

Materials
All the solvents were purified by standard proce dures [32] and stored over molecular sieves type 4 A. All other chemicals were reagent grade. The carbo hydrate starting materials 4, 6, 8, 20 and 24 were prepared by the known methods [33] [34] [35] [36] [37] , The nitroxyl radicals were synthesized according to the literature methods [38, 39] .
Analytical procedures
Melting points were determ ined on a Thomas H oover apparatus, model 6406-k with a calibrated therm om eter. The IR spectra were recorded on a Nicolet-IOM X FT-IR spectrophotom eter. Mass spectra were recorded on a Hewlett-Packard mass spectrom eter, model 5985 GS, using a direct inser tion probe, a source pressure of 2 x l 0~7 torr and m ethane as a reactant gas for chemical ionization or electron impact. Therefore, either the M + + l or M + values are reported. The E PR spectra of 1CT4 M solu tions of the nitroxyl derivatives were recorded, using either w ater or m ethanol as a solvent, on a Varian E-115 E P R spectrom eter. Microanalyses were per form ed on a Perkin-Elm er 240 C elem ental analyzer. Column chrom atography was perform ed by using the flash chrom atographic technique [40] on silica gel 6 0 C Fluka, finer than 230 mesh.
The progress of reactions and purity control of products were m onitored by TLC analyses using sili ca gel 6OF254 precoated sheets (EM Reagents), layer thickness 0.2 mm with visualization using either UV light and/or iodine chamber. Relaxation times were m easured at 23.5 °C using saturation recovery m ethod for T[ and spin-echo technique for T2 on a Praxis pulsed NM R analyzer, model PR-103, 10.7 M Hz, 0.251 Tesla, the Praxis C o., San A ntonio, Texas, U .S .A . The specific rotations were measured using a SR -6 polarim eter, Polyscience C orp., Il linois, U .S .A . 
To a solution of 8 [35] (0.696 g, 2 mmol) in to luene (25 ml) was added a solution of 4-chloro-2,2,6,6-tetram ethylpiperidine-l-oxyl (9, 0.401 g, 2.10 mmol) in pyridine (20 ml) at 0 °C. The reaction mixture was stirred at 0 °C for 4 h, followed by stir ring overnight at 25 °C. To the reaction mixture anhydrous ether (50 ml) was added and the precipi tated pyridinium hydrochloride salt was removed by filtration. The filtrate was concentrated on a rotating evaporator at 40 °C/20 torr.
Purification of the thick, red oil by flash chrom atography on silica gel 60, using chloroform and m ethanol 
Starting with 10 (0.502 g, 1 mmol) a procedure similar to that for the preparation of 7 was used to give 0. 
Preparation o f l-0 -(2 ',2 ',6 ',6'-tetram ethyl-lf-oxyl-4' -piperidine-4'-carbonyl)-2,3,4,6-tetra-0-acetyl-D-glucopyranose (13)
To a stirred solution of 8 [35] (0.696 g, 2 mmol) in toluene (25 ml) was added dropwise a solution of 4-chloroform yl-2,2,6,6-tetram ethylpiperidine-l-oxyl (12, 0.459 g, 2.10 mmol) in pyridine (25 ml). The reaction mixture was stirred for 6 h at 0 °C and then for 8 h at 25 °C. To this mixture anhydrous ether (50 ml) was added. The solid was rem oved by filtra tion and the filtrate was evaporated to dryness on a rotating evaporator at 40 
Preparation o f l-0-(2',2 ',6 ',6'-tetramethyl-1'-oxyl-4 '-piperidine-4'-carbonyl)-D-glucopyranose (14)
The procedure for the preparation of 7 was adopted in the preparation of 14. Thus, to 13 (0.530 g, 1 mmol) was added m ethanolic ammonia (40 ml) 
Preparation o f 2-deoxy-2-(2 ',2 ',5 ',5 '-tetramethyl-1 '-oxy 1-3' -pyrroline-3'-carbony lamido)-D-glucopyranose (17)
A solution of 2,2,5,5-tetramethyl-l-oxyl-3-pyrroline-3-carboxylic acid-N-hydroxysuccinimide ester (18, 0.702 g, 2.50 mmol) in tetrahydrofuran (20 ml) was added rapidly to a stirred solution of D-( + )-glucosamine hydrochloride (15, 0.537 g, 2.50 mmol) and sodium bicarbonate (0.336 g, 4.00 mmol) in wa ter (25 ml). A fter 40 h of stirring at 25 °C the yellow solution was concentrated on a rotating evaporator at 50 °C/20 torr and the residue was triturated with boiling ethanol (50 ml) and filtered. The filtrate was concentrated on a rotating evaporator at 40 °C/ 20 torr. The residue was dissolved in water (25 ml) and the solution passed successively through Amberlite IRC-50 and IR-45 columns using water as eluant. The eluate was concentrated on a rotating evaporator at 50 °C/20 torr to give a yellow, oily m aterial which was dissolved in a mixture of acetone and ethyl acetate (2 :3 , v/v, 10 ml). The solution was kept for 12 h at 25 °C. The separated semi-solid m aterial was isolated by decantation and purified by flash chrom atography on silicagel 60, using a mixture of heptane and t-butyl methyl ether 
Preparation o f 6-deoxy-6-(2',2 ',6 ',6'-tetramethyl-1 '-oxy 1-4' -piperidine-4'-amino-carbonyl)-1,2-isopropylidene-D-glucopyranose (22)
To a stirred solution of D-( + )-glucurono-l,2-isopropylidene-3,6-lactone (20) [34] 
Preparation o f 6-deoxy-6-(2',2 ',6',6 '-tetramethyl-1 '-oxy 1-4' -piperidine-4' -amino-carbony I)-a-D-glucose (23)
A solution of 22 (0.387 g, 1 mmol) in 0.02 N aque ous oxalic acid (25 ml) was boiled with reflux for 3 h. A fter cooling to 25 °C, the reaction mixture was ex tracted with ethyl acetate (2x20 ml) and the extracts were discarded. The aqueous layer was thoroughly mixed with a slurry of freshly prepared barium car bonate (15 ml, prepared from 0.250 g of barium hydroxide octahydrate and 2.0 g of solid carbon dioxide and 10 ml of water) and the mixture stirred 
Preparation o f methyl 6-0-(2',2 ',5 ',5 '-tetramethyl-1 '-oxyl-3' -pyrroline-3'-carbonyl)-a-D-glucopyranoside (26)
Distilled 
Preparation o f methyl 6-0-(2' ,2' ,6 ' ,6'-tetramethyl-1'-oxyl-4' -piperidine-4' -carbonyl)-2,3,4-tri-O-trimethylsilyl-a-D-glucopyranoside (27)
A solution of compound 24 [36] (0.602 g, 1.5 mmol) and 4-chloroformyl-2,2,6,6-tetramethylpiperidine-l-oxyl (12) (0.346 g, 1.58 mmol) in py ridine (10 ml) was stirred at 0 °C for 12 h. The w ork up was the same as that described in the preparation of 25. Compound 27 0.699 g (78%) was a red, thick oil. 
Preparation o f methyl 6-0-(2',2 ',6 ',6 '-tetramethyl-1 '-oxyl-4' -piperidine-4'-carbonyl)-2,3,4-tri-O-trimethylsilyl-a-D-glucopyranoside (29)
Distilled water was added to a solution of 27 (0.593 g, 1 mmol) in methanol (30 ml) until cloudi ness appeared. The reaction mixture was boiled with reflux for 6 h. The work-up was the same as that described in the preparation of 26. 
Preparation o f 25 by the D C C ID M AP method
To a solution of 2,2,5,5-tetramethyl-3-carboxy-3-pyrroline-l-oxyl (5, 0.266 g, 1.50 mmol), 4-dim ethylaminopyridine (D M A P, 0.015 g, 0.1 mmol) and methyl 2,3,4-tri-0-trimethylsilyl-a-D-glucopyranoside (24 [36] , 0 .622 g, 1.55 mmol) in tetrahydrofuran (25 ml) was added dicyclohexylcarbodiimide (DCC, 0.326 g, 1.55 mmol). The reaction mix ture was stirred for 24 h at 25 °C, and the separated dicyclohexyl urea removed by filtration. The filtrate was dried over anhydrous magnesium sulfate and the salt was removed by filtration. The filtrate was con centrated at 40 °C/20 torr on a rotating evaporator. The remaining thick, yellow liquid was purified by flash chromatography on silica gel 60, using a mix ture of f-butyl methyl ether and «-heptane (1:1, v/v) as eluant. Compound 25 0.688 g (77%) was obtained as a thick viscous liquid. This compound was identi cal in all respects to the compound 25 prepared by a different m ethod (Path I, Scheme IV).
Preparation o f 26
This com pound was prepared from 25 (Path II, Scheme IV) by an analogous m ethod as that used for the preparation of 26 (Path I, Scheme IV).
Preparation o f 21 by the D C C /D M A P method
To a solution of 2,2,6,6-tetramethyl-4-carboxypiperidine-l-oxyl (28) (0.300 g, 1.50 mmol), 4-dim ethylam inopyridine (D M A P, 0.15 g, 0.1 mmol) and methyl 2,3,4-tri-O-trimethylsilyl-a-D-glucopyranoside (24, 0.622 g, 1.55 mmol) in tetrahydrofuran (25 ml) was added dicyclohexyl carbodiimide (0.326 g, 1.55 mmol). The reaction mixture was stir red for 24 h at 25 °C and the separated dicyclohexylurea rem oved by filtration. The filtrate was dried over anhydrous magnesium sulfate and the salt re moved by filtration. The filtrate was concentrated at 40 °C/20 torr on a rotating evaporator to afford a thick, red liquid. Purification of this liquid by flash chrom atography on silica gel 60, using a mixture of r-butyl methyl ether and /7-heptane (1:1, v/v) as eluant gave 0.740 g (80%) of 27 as a thick, red oil. This com pound was found to be identical in all re spects with the compound 27 prepared by a different m ethod (Path I, Scheme V).
Preparation o f 29 by D C C /D M A P method
This com pound was prepared from 27 (Path II, Scheme V) by an analogous m ethod as that used for the preparation of 29 (Path I, Scheme V). 
A mixture of 31 (0.470 g, 1.1 mmol) in 0.01 N aqueous oxalic acid (20 ml) was heated to reflux for 2 h [41] , A fter cooling to 25 °C, the reaction mixture was extracted with ethyl acetate (20 ml) and the extract discarded. The aqueous layer was mixed with a slurry (10 ml) of freshly prepared barium carbonate (from 0.250 g of barium hydroxide octahydrate and 2.0 g of solid carbon dioxide in 10 ml of water). The mixture was stirred for 5 min and filtered. The pale yellow filtrate was concentrated on a rotating evaporator at 40 °C/20 to rr to give a crude 33 in the form of a yel low, oily liquid. Purification of this liquid by flash chrom atography on silica gel 60, using a mixture of chloroform and methanol ( To a stirred suspension of sodium hydride (50% , 0.50 g, 5.2 mmol) in dry tetrahydrofuran (12 ml) was added dimethylsulfoxide (2 ml), followed by 1,2,5,6-diacetone-D-glucose (30, 0.780 g, 3.0 mmol). The reaction mixture was stirred at 25 °C until the evolu tion of hydrogen ceased (~1 0 min). To this mixture a solution of 34 (0.960 g, 3.0 mmol) in dry tetra hydrofuran (5 ml) was rapidly added, and the reac tion mixture heated at reflux for 30 min, followed by stirring for 24 h at am bient tem perature. Inorganic salts and the excess of sodium hydride were removed by filtration and the solid washed with dry ethyl ether (2 x 1 0 ml). Concentration of the combined washings and filtrate on a rotating evaporator initially at 40 °C/ 20 to rr and then at 60 °C/1 to rr gave crude 35 
Preparation o f 3-0-[5'-(2",2",6",6"-tetramethyl-1"-oxyl-4"-piperidinyl)pentyI]-D-glucopyranose (36)
A solution of 35 (0.690 g, 1.37 mmol) in m ethanol (60 ml) containing 10% Pd/C catalyst (0.200 g) was hydrogenated under initial hydrogen pressure of 50 psi. A fter 3 h the catalyst was re moved by filtration. Concentration of the colorless filtrate on a rotating evaporator at 40 °C/20 torr gave 0.690 g of an oily m aterial, which was uniform by TLC analysis (silica gel, h e p ta n e : /-butyl methyl ether, 1:1, v/v). In contrast to the starting m aterial, this product could not be visualized on the TLC plate using UV light. This result indicates the ab sence of the nitroxyl moiety in the molecule. The material was dissolved in a 2 N aqueous hydro chloric acid (12 ml) and the solution stirred for 3 h at 25 °C [42] . The solution was carefully neutralized using solid sodium bicarbonate (2.5 g) and the reac tion mixture concentrated to dryness on a rotating evaporator at 40 °C/20 torr. The solid residue was triturated once with ethyl acetate (25 ml) and three times with absolute ethanol (25 ml each). Concen tration of the combined extracts on a rotating evaporator at 40 °C/20 torr gave a colorless oily re sidue which was immediately dissolved in water (22 ml). To this solution sodium tungstate (0.30 g) and a 30% aqueous hydrogen peroxide solution (5.0 ml) was added and the reaction mixture was kept in the dark for 48 h at 25 °C. Further 30% hydrogen peroxide solution (1.0 ml) was added aft er the first 24 h. Concentration of the reaction mix ture on a rotating evaporator at 40 °C/20 torr gave the semi-solid residue which was triturated with m ethanol (10 ml) and filtered. C oncentration of the red filtrate at 40 °C/20 torr gave the crude 36 in the form of a red, oily liquid. Purification of this m ate rial by flash chrom atography on silica gel 60 using a mixture of chloroform and methanol (5: 
